Page last updated: 2024-08-21

cyclopentane and 6-ketoprostaglandin f1 alpha

cyclopentane has been researched along with 6-ketoprostaglandin f1 alpha in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bauersachs, J; Busse, R; Fleming, I; Popp, R; Scholz, D1

Other Studies

1 other study(ies) available for cyclopentane and 6-ketoprostaglandin f1 alpha

ArticleYear
Endothelium-derived hyperpolarizing factor, but not nitric oxide, is reversibly inhibited by brefeldin A.
    Hypertension (Dallas, Tex. : 1979), 1997, Volume: 30, Issue:6

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta; Biological Factors; Bradykinin; Brefeldin A; Cells, Cultured; Coronary Vessels; Cyclic GMP; Cyclopentanes; Drug Synergism; Endothelium, Vascular; Golgi Apparatus; Humans; In Vitro Techniques; Membrane Potentials; Muscle Contraction; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Rabbits; Swine; Umbilical Veins; Vasodilation

1997